Hepatitis B virus infection in Haemodialysis Centres from Santa Catarina State, Southern Brazil. Predictive risk factors for infection and molecular epidemiology

BMC Public Health

Volumn 4, Issue , 2004, Pages 1-38

  Carrilho, Flair J ^a,d   Moraes, Cleusa R ^a   Pinho, João R R ^b   Mello, Isabel M V G C ^b   Bertolini, Dennis A ^b   Lemos, Marcílio F ^b   Moreira, Regina C ^b   Bassit, Leda C ^c   Cardoso, Rita A ^a   Ribeiro Dos Santos, Gabriela ^a   Da Silva, Luiz C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO ADOLFO LUTZ   (Brazil)

^c FUNDAÇÃO PRÓ SANGUE HEMOCENTRO DE SÃO PAULO   (Brazil)

^d University of São Paulo ^*  (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ARTIFICIAL KIDNEY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GENE SEQUENCE; GENOTYPE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HOSPITAL HYGIENE; HOSPITAL PERSONNEL; HUMAN; INFECTION RATE; INFECTION RISK; INSTRUMENT STERILIZATION; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION; RECYCLING; SUPERINFECTION; VIREMIA;

EID: 2642563816     PISSN: 14712458     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2458-4-13     Document Type: Article

References (52)

1. Carrilho FJ, Corrêa MCJM. Magnitude of hepatitis B and C in Latin America. In Therapy for Viral Hepatitis. Edited by Schinazi RF, Somadossi, JP, Thomas HC. London: Int Med Press; 1998: 25-34.
2. Garibaldi RA, Forrest JN, Bryan JA, Hanson BF, Dismukes WE. Hemodialysis-associated hepatitis. J Amer Med Assoc 1973, 225:384-389.
3. Goffin E, Pirson Y, Strihou CVY. Implications of chronic hepatitis B or hepatitis C infection for renal transplant candidates. Nephrol Dial Transplant 1995, 10 Suppl 61:88-92.
4. Castro-Figueiredo JF, Moyse Neto M, Gomes UA, Spalini-Ferraz A, Nardin-Batista MEP, Coimbra-Gaspar AM, Tachibana-Yoshida CF. Hepatitis B virus infection in hemodialysis units: clinical features, epidemiolgical markers and general control measures. Brazilian J Med Biol Res 1986, 19:735-742.
5. Brancroft WH. The geographical distribution of HBsAg subtypes. Bibl Haemato 1976, 42: 42-47.
6. Couroucé-Pauty AM, Plançon A, Soulier JP. Distribution of HBsAg subtypes in the World. Vox Sang 1983, 44:197-211.
7. Okamoto BH, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, Miyakawas Y, Mayumi M. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 1988, 69: 2575-2583.
8. Norder H, Hammas B, Lofdahl S, Courouce AM, Magnius LO. Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains. J Gen Virol 1992, 73:1201-1208.
9. Norder H, Hammas B, Magnius LO. Molecular basis of hepatitis B virus serotype variations within the four major subtypes. J Gen Virol 1992, 73:3141-3145.
10. Stuyver L, Gendt SD, Geyt CV, Zoulim F, Fried M, Schinazi RF, Rossau R. A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol 2000, 81:67-74.
11. Arauz-Ruiz P, Norder H, Robertson BH, Magnius LO. Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol 2002, 83: 2059-2073.
12. Dumpis U, Holmes EC, Mendy M, Hill A, Thursz M, Hall A, Whittle H, Karayiannis P: Transmission of hepatitis B virus infection in Gambian families revealed by phylogenetic analysis. J Hepatol. 2001, 35: 99-104.
13. Gaspar AM, Yoshida CF: Geographic distribution of HBsAg subtypes in Brazil. Mem Inst Oswaldo Cruz 1987, 82: 253-258.
14. Kaneko S, Feinstone SM, Miller RH. Rapid and sensitive method for the detection of serum hepatitis B virus DNA using the Polymerase Chain Reaction technique. J Clin Microbiol 1989, 27: 1930-1933.
15. Sitnik R, Pinho JRR, Da Silva LC, Fonseca LEP, Carrilho FJ, Bernardini AP. Hepatitis B Virus Genotypes and Pre Core Mutants in Chronic Hepatitis B Patients from São Paulo City, Brazil [abstract]. Hepatology 2000, 32 (4 Pt.2):587A.
16. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977, 74: 5463.
17. Kumar S, Tamura K, Jakobsen IB, Nei M. MEGA2: molecular evolutionary genetics analysis software. Bioinformatics 2001, 17:1244-1245.
18. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The Clustal X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucl Ac Res 1997, 24: 4876-4882.
19. Kimura M. A simple method for estimating evolutionary rates of bases substitutions through comparative studies of nucleotide sequences. J Mol Evol 1980, 16:111-120.
20. Cox DR: The analysis of Binary data. London: Methuen; 1970.
21. Cary NC: SAS/STAT User's guide. Volume 2. 4th edition. New York: Statistical Analysis System Institute Inc.; 1989.
22. Moraes CR. Estudo epidemiológico caso - controle da infecção pelo vírus da hepatite C em pacientes e funcionários das Unidades de Diálise do Estado de Santa Catarina. PhD thesis. University of São Paulo School of Medicine, Department of Gastroenterology; 1998.
23. Ministry of Health - Brazil. Decree number 2,042.
24. Ashraf SJ, Arya SC, Parande CM. Viral hepatitis markers in patients on haemodialysis in a hyperendemic area. J Med Virol 1986, 19: 41-46.
25. Oguchi H, Miyasaka M, Tokunaga S, Hora K, Ichikawa S, Ochi T, Yamada K, Nagasawa M, Kanno Y, Aizawa T, Watanabe H, Yoshizawa S, Sato K, Terashima M, Yoshie T, Oguchi O, Tanaka E, Kiyosawa K, Furuta S. Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units. Clin Nephrol 1992, 38:36-43.
26. Mattos AA, Flores AL, Coral GP, Goldani JC, Losekann A, Becker M, Asquidamini S, Fossati L. Incidência dos marcadores virais para a hepatite B e resposta a vacinação em uma unidade de hemodiálise. Gastroenterol Endosc Digest 1999, 18:193-196.
27. Cendoroglo Neto M, Draibet SA, Silva AEB, Ferraz ML, Granato C, Pereira CAP, Sesso RC, Gaspar AMC, Ajzen H. Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among haemodialysis and CAPD patients: evidence for environmental transmission. Nephrol Dial Transplant 1995, 10: 240-246.
28. Ianhez LE, Cuelar MKS, Leaf C, Saldanha LB, Romáo Jr JE, Sabbaga E. Prognóstico hepático em pacientes transplantados com HBsAg positivo pré-transplante. Rev Hosp Clín Fac Med, S Paulo 1985, 40: 53-57.
29. Kopstein J, Ugalde CB, Fiori AMC.Hemodiálise e hepatite a vørus B. J Bras Nefrol 1984, 6: 9-11.
30. Pinho JRR, Fares J, Oba IT, Siqueira ML, Moreira RC, Barreto CC, Alquezar AS. Acompanhamento dos marcadores das hepatites B e C em uma unidade de diálise [abstract]. Rev Soc Bras Med Trop 1994, 27 Suppl: 372.
31. Romão Jr JE. Hepatite B em hemodiálise. J Bras Nefrol 1094, 6: 2-3.
32. Teles SA, Martins RMB, Vanderborght B, Stuyver L, Gaspar AMC, Yoshida CFT. Hepatitis B virus: genotypes and subtypes in Brazilian hemodialysis patients. Artif Org 1999, 23:1074-1078.
33. Paraná R, Cotrim H, Mascarenhas R, Dutra M, Lyra, L. Incidence of markers of hepatitis B and C in patients undergoing hemodialysis [abstract]. Acta Hepatol 1991, 1:23.
34. Cendoroglo Neto M, Manzano SIR, Canziani ME, Silva AEB, Cirenza MLF, Sesso RC, Ajzen H, Draibe SA. Environmental transmission of hepatitis B and hepatitis C viruses within the hemodialysis unit. Artif Org 1995, 19:251-255.
35. Fernandes JV, Braz RFS, Neto FVA, Silva MA, Costa NF, Ferreira AM. Prevalence of serologic markers of the hepatitis B virus in hospital personnel. Rev Saúde Púb 1999, 33:122-128.
36. Levy BS, Harris JC, Smith JL, Washburn JW, Mature J, Davis A, Crosson JT, Polesky H, Hanson M. Hepatitis B in ward and clinical laboratory employees of a general hospital. Amer J Epidemiol 1977, 106:330-335.
37. Ayoola EA, Huraib S, Arif M, Al-Faleh FZ, Al-Rashed R, Ramia S, AL-Mofleh IA, Abu-Aisha H. Prevalence and significance of antibodies to hepatitis C virus among Saudi haemodialysis patients. J Med Virol 1991, 35:155-159.
38. Beccari M, Sorgato G, Rizzolo L, Veneroni G. Anti-HCV reactivity in dialysis patients: discrepancies between first and second generation tests [letter]. Nephron 1983, 63:238.
39. Chan TM, Lok ASF, Cheng IKP. Hepatitis C infection Among dialysis patients: a comparison between patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1991, 6:944-947.
40. Dussol B, Chicheportiche C, Cantaloube J, Roubicek C, Biagini P, Berthézène P, Berland Y. Detection of hepatitis C infection by polymerase chain reaction among hemodialysis patients. Amer J Kidney Dis 1993, 22:574-580.
41. Dussol B, Berthezène P, Brunet P, Roubicek C, Berland Y. Hepatitis C virus infection among chronic dialysis patients in the South of France: a collaborative study. Amer J Kidney Dis 1995, 25: 399-404.
42. Elisaf M, Tsianos E, Mavridis A, Dardamanis M, Pappas M, Siamopoulos KC. Antibodies against hepatitis C virus (anti-HCV) in haemodialysis patients: association with hepatitis B serological markers. Nephrol Dial Transplant 1991, 6: 476-479.
43. Fabrizi F, Raffaele G, Bacchini G, Guarnori I, Pontoriero G, Erba G. Antibodies to hepatitis C virus and transaminase concentration in chronic haemodialysis patients: a study with second - generation assays. Nephrol Dial Transplant 1993, 8:744-747.
44. Kellerman S, Alter MJ. Preventing hepatitis B and hepatitis C virus infections in end-stage renal disease patients: back to basics. Hepatology 1999, 29:291-293.
45. Lin D, Lin H, Huang C, Liaw Y. High incidence of hepatitis C virus infecction in hemodialysis patients in Taiwan. Amer J Kidney Dis 1993, 21:288-291.
46. a geração da prevalência de anticorpos da Hepatite C (soro e extrato sérico de papel de filtro) em uma unidade de transplante renal. Rev Bras Pat Clín 1993, 29:14-19.
47. Machida J, Yamaguchi K, Ueda S, Yoshida M, Kusumoto Y, Nishimura Y, Futami G, Ishii T, Watanabe T, Takatsuki KI. High incidence of hepatitis virus antibodies in hemodialysis patients. Nephron 1992, 60:117-118.
48. Garcia VD. Reuso dos dialisadores: formaldeído ou ácido peracético? J Bras Nefrol 1994, 16:55-57.
49. Centers for Disease Control and Prevention. Guidelines for Dialysis Centers. Dial Transplant 1989, p. 543-55.
50. Snydman DR, Bryan JA, London WT, Werner B, Bregm ND, Blumberg BS, Gregg MB. Transmission of hepatitis B associated with hemodialysis: role of malfunction (blood leaks) in dialysis machines. J Infec Dis 1976, 134:562-570.
51. Lyerla R, Kellerman S, Alter MJ.Hepatitis B and hemodialysis: the impact of universal precautions in preventing the transmission of bloodborne viruses. Letter to the editor. Infect Control Hosp Epidemiol 1999, 20:156.
52. Favero MS, Alter MJ. The reemergence of hepatitis B virus infection in hemodialysis centers. Sem Dialysis 1996, 9:373-374.